ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Alchemab Therapeutics Ltd

Alchemab Therapeutics Ltd is an active company incorporated on 14 August 2019 with the registered office located in London, Greater London. Alchemab Therapeutics Ltd was registered 6 years ago.
Status
Active
Active since incorporation
Company No
12156844
Private limited company
Age
6 years
Incorporated 14 August 2019
Size
Large
Did not meet the 2-out-of-3 criteria for Medium size or smaller.
Confirmation
Submitted
Dated 28 November 2025 (1 month ago)
Next confirmation dated 28 November 2026
Due by 12 December 2026 (11 months remaining)
Last change occurred 23 days ago
Accounts
Submitted
For period 1 Jan ⟶ 31 Dec 2024 (1 year)
Accounts type is Medium
Next accounts for period 31 December 2025
Due by 30 September 2026 (8 months remaining)
Learn more about Alchemab Therapeutics Ltd
Contact
Address
East Side Office 1.02
Kings Cross
London
N1C 4AX
United Kingdom
Same address for the past 4 years
Telephone
020 80784357
Email
Unreported
See All Contacts
People
Officers
5
Shareholders
41
Controllers (PSC)
1
Dame Catherine Elizabeth Bingham
Director • British • Lives in UK • Born in Oct 1965
Andrew David Levin
Director • American • Lives in United States • Born in Nov 1976
Kevin Lee
Director • English • Lives in England • Born in Apr 1968
John Hamer
Director • American • Lives in United States • Born in Dec 1957
Jane Katharine Osbourn
Director • British • Lives in England • Born in Mar 1966
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
SV Health Investors UK Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Pulmocide Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Bicyclerd Limited
Kevin Lee is a mutual person.
Active
Autifony Therapeutics Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Sitryx Therapeutics Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Enara Bio Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Bicycle Therapeutics Plc
Kevin Lee is a mutual person.
Active
Bicycletx Limited
Kevin Lee is a mutual person.
Active
See All Mutual Companies
Brands
Alchemab Therapeutics
Alchemab Therapeutics focuses on developing antibody therapeutics for difficult-to-treat diseases by studying resilient individuals to understand how they overcome these diseases..
Financials
Net Assets, Total Assets & Total Liabilities (2020–2024)
Period Ended
31 Dec 2024
For period 31 Dec ⟶ 31 Dec 2024
Traded for 12 months
Cash in Bank
£15.58M
Increased by £2.26M (+17%)
Turnover
£1.59M
Increased by £1.59M (%)
Employees
60
Decreased by 5 (-8%)
Total Assets
£22.44M
Decreased by £3.25M (-13%)
Total Liabilities
-£31.77M
Increased by £23.86M (+301%)
Net Assets
-£9.34M
Decreased by £27.11M (-153%)
Debt Ratio (%)
142%
Increased by 110.81% (+360%)
See 10 Year Full Financials
Latest Activity
Confirmation Submitted
23 Days Ago on 12 Dec 2025
Medium Accounts Submitted
3 Months Ago on 2 Oct 2025
Group Accounts Submitted
1 Year Ago on 3 Jan 2025
Confirmation Submitted
1 Year 1 Month Ago on 29 Nov 2024
Jane Katharine Osbourn Appointed
1 Year 3 Months Ago on 11 Sep 2024
Young T. Kwon Resigned
1 Year 3 Months Ago on 11 Sep 2024
Confirmation Submitted
2 Years 1 Month Ago on 1 Dec 2023
Group Accounts Submitted
2 Years 5 Months Ago on 8 Aug 2023
Houman Ashrafian Resigned
2 Years 5 Months Ago on 26 Jul 2023
Dame Catherine Elizabeth Bingham Appointed
2 Years 5 Months Ago on 26 Jul 2023
Get Alerts
Get Credit Report
Discover Alchemab Therapeutics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Confirmation statement made on 28 November 2025 with updates
Submitted on 12 Dec 2025
Statement of capital following an allotment of shares on 5 November 2025
Submitted on 20 Nov 2025
Statement of capital following an allotment of shares on 22 October 2025
Submitted on 22 Oct 2025
Accounts for a medium company made up to 31 December 2024
Submitted on 2 Oct 2025
Statement of capital following an allotment of shares on 26 August 2025
Submitted on 28 Aug 2025
Statement of capital following an allotment of shares on 3 July 2025
Submitted on 31 Jul 2025
Change of share class name or designation
Submitted on 28 Jul 2025
Particulars of variation of rights attached to shares
Submitted on 28 Jul 2025
Resolutions
Submitted on 16 Jul 2025
Memorandum and Articles of Association
Submitted on 16 Jul 2025
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs